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REVIEW

A decade of the anaphase-promoting
complex in the nervous system
Ju Huang and Azad Bonni
Department of Neuroscience, Washington University School of Medicine, St. Louis, Missouri 63110, USA

Protein degradation regulates diverse biological processes
in the developing and mature nervous system. Spatial and
temporal control of protein turnover and abundance influences distinct stages of neural development and function
from neurogenesis and neuronal morphogenesis to synapse formation and pruning to plasticity and learning
(Hegde and Upadhya 2007; Yi and Ehlers 2007; Segref
and Hoppe 2009; Yamada et al. 2013). Protein degradation
by the proteasome requires ubiquitination, which is mediated by the sequential action of an E1 ubiquitin-activating
enzyme, E2 ubiquitin-conjugating enzyme, and E3 ubiquitin ligase (Hershko and Ciechanover 1992; Scheffner et al.
1995; Ciechanover 2005; Hershko 2005; Weissman et al.
2011). Two E1, ∼40 E2, and >600 E3 enzymes are encoded
in the human genome (Haas and Rose 1982; Pickart 2001;
Ye and Rape 2009). E3 ubiquitin ligases are divided into
two major classes, the HECT domain and RING domain
families. RING domain E3 ubiquitin ligases, consisting
of single subunit or multisubunit enzymes, represent
the largest group and display wide-ranging functions within the cells. The large number of E3 ubiquitin ligases

reflects their critical role in substrate specificity in the
ubiquitination reaction (Deshaies and Joazeiro 2009; Rotin
and Kumar 2009; Komander and Rape 2012).
The anaphase-promoting complex is a major E3 ubiquitin ligase and member of the RING domain family. First
identified in genetic and biochemical studies of Cyclin B
ubiquitination two decades ago (Irniger et al. 1995; King
et al. 1995; Sudakin et al. 1995), the anaphase-promoting
complex is a large complex of 15 subunits in vertebrates
(Chang et al. 2014). Cdh1 and Cdc20 constitute two key
regulatory subunits of this complex (Visintin et al. 1997).
The association of Cdh1 or Cdc20 stimulates the catalytic
activity of the anaphase-promoting complex and specifies
substrate recognition (Harper et al. 2002; Peters 2006;
Chang et al. 2015). Cdh1–anaphase-promoting complex
(Cdh1–APC) and Cdc20–APC recognize substrates via a
peptide motif, termed the destruction box (D box), within
substrates (Glotzer et al. 1991; Zachariae and Nasmyth
1999; Burton and Solomon 2001). Cdh1–APC associates
with substrates through additional recognition motifs,
including the KEN and A boxes (Pfleger and Kirschner
2000; Littlepage and Ruderman 2002). The Cul1-related
scaffold protein APC2 and the RING finger protein APC11
form the catalytic core of the anaphase-promoting complex (Harper et al. 2002; Peters 2006). Other subunits
act as scaffold proteins, coordinating the juxtaposition of
the catalytic and degron recognition modules of the complex (Passmore et al. 2005; Schreiber et al. 2011). Several
scaffolding subunits, including APC3 (Cdc27), APC6
(Cdc16), APC8 (Cdc23), APC5, and APC7, contain tetratricopeptide repeat (TPR) motifs (Schreiber et al. 2011; Chang
et al. 2015).
Although the anaphase-promoting complex in budding yeast collaborates with the E2s Ubc1 and Ubc4 that
catalyze the assembly of K48-linked polyubiquitin chains
of substrates (Rodrigo-Brenni and Morgan 2007), several ubiquitin chains of complex topology are generated
through multiple lysine residues, including K11 and K63
in addition to K48 (Kirkpatrick et al. 2006). The human anaphase-promoting complex and its E2, UbcH10,
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Control of protein abundance by the ubiquitin–proteasome system is essential for normal brain development
and function. Just over a decade ago, the first post-mitotic
function of the anaphase-promoting complex, a major cell
cycle-regulated E3 ubiquitin ligase, was discovered in the
control of axon growth and patterning in the mammalian
brain. Since then, a large number of studies have identified
additional novel roles for the anaphase-promoting complex in diverse aspects of neuronal connectivity and plasticity in the developing and mature nervous system. In
this review, we discuss the functions and mechanisms
of the anaphase-promoting complex in neurogenesis, glial
differentiation and migration, neuronal survival and metabolism, neuronal morphogenesis, synapse formation
and plasticity, and learning and memory. We also provide
a perspective on future investigations of the anaphase-promoting complex in neurobiology.
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preferentially assemble K11-linked branched ubiquitin
chains on substrates to drive proteasomal degradation
and mitotic exit (Jin et al. 2008). Branched ubiquitin chains
that contain multiple blocks of K11-linked chains enhance
substrate recognition by the proteasome (Meyer and Rape
2014). In a recent study using single-molecule kinetic analyses, Lu et al. (2015) characterized the role of ubiquitin
configurations of substrates on proteasome binding and
subsequent degradation. The total number of ubiquitin
molecules rather than ubiquitin chain configuration on
substrates of the anaphase-promoting complex determines the strength of binding of substrates with the proteasome (Lu et al. 2015). However, the configuration of
ubiquitin chains on substrates determines degradation
efficiency by affecting the translocation of substrates
into the proteasome. A distributed array of short ubiquitin chains on substrates of the anaphase-promoting
complex is a superior and optimal signal for degradation
(Lu et al. 2015).

Structure of the anaphase-promoting complex
Elucidation of the structure of the anaphase-promoting
complex is essential to understanding the function of this
major E3 ubiquitin ligase. Crystallographic analyses of isolated subunits and small subcomplexes of the anaphasepromoting complex followed by cryo-electron microscopy
(cryo-EM) studies have revealed the molecular architecture of this E3 ubiquitin ligase with its coactivators, subunit stoichiometry, and position of subunits as well as
the coactivators Cdh1 and Cdc20 (Dube et al. 2005; Passmore et al. 2005; Ohi et al. 2007; Herzog et al. 2009). These
studies have painted a picture of a triangular-shaped complex ∼1.7 MDa in mass and 19 × 17 × 15 nm in size (Passmore et al. 2005; Ohi et al. 2007).
Recent cryo-EM studies have refined our understanding
of the precise relationship of individual subunits within
Cdh1–APC and how ubiquitination of substrates operates
and inhibitors block ubiquitin ligase function (Frye et al.

2013; He et al. 2013; Chang et al. 2014, 2015; Yamaguchi
et al. 2015). Reconstruction of Cdh1–APC by cryo-EM
has largely confirmed the triangular shape of Cdh1–APC
delineated by a lattice-like shell comprised of a catalytic “platform” and an “arc lamp” scaffolding structure
(Fig. 1; Chang et al. 2014; Yamaguchi et al. 2015). Positioned at the periphery of the platform is the catalytic
core, consisting of APC2 and APC11. The platform also includes APC1, APC4, APC5, and APC15. The arc lamp contains the subunits APC3, APC6, APC7, APC8, APC10,
APC12, APC13, and APC16. The curved structure of the
arc lamp, which serves as a scaffold for the recruitment
of substrates, is established by layers of the TPR proteins
APC8, APC6, APC3, and APC7 stacked on top of each other. Notably, APC10 contributes to the substrate D-box recognition module (da Fonseca et al. 2011; Chang et al. 2014).
The homologous isoleucine–arginine “IR tail” sequences
at the C terminus of APC10 and Cdh1 (or Cdc20) bind
the APC3 homodimer. Thus, APC10 may act as a coreceptor for Cdh1–APC or Cdc20–APC substrates (Izawa and
Pines 2011; Chang et al. 2014).
The structural basis of Cdh1 stimulation of the catalytic activity of Cdh1–APC has also been revealed. The
N-terminal domain of Cdh1 triggers displacement of
the catalytic subunits APC11 and APC2 relative to the
D-box recognition module of Cdh1 and APC10. This allosteric transition is accompanied by increased flexibility of
the catalytic subunits and enhanced affinity for E2–ubiquitin, thus stimulating the catalytic activity of Cdh1–
APC (Chang et al. 2014). The structural basis of inhibition
of the anaphase-promoting complex by the protein interphase early mitotic inhibitor 1 (Emi1) has also been studied. Emi1 interacts with both the substrate recognition
module of Cdh1 and the catalytic module of Cdh1–APC
(Reimann et al. 2001; Frye et al. 2013; Chang et al. 2015),
thereby inhibiting the substrate recruitment and catalytic
activity of Cdh1–APC. Furthermore, the interaction of
Emi1 with Cdh1–APC blocks the binding of the E2
UbcH10 with APC11 and thus inhibits ubiquitin chain
elongation (Frye et al. 2013), suggesting that Emi1 directly

Figure 1. EM reconstruction of the anaphase-promoting complex. The anaphasepromoting complex is a large complex of
15 subunits in vertebrates. It is triangularshaped, ∼1.7 MDa in mass, and 19 × 17 × 15
nm in size. Cdh1 and Cdc20 constitute
two key regulatory subunits of the anaphase-promoting complex. The Cul1-related scaffold protein APC2 and the RING
finger protein APC11 form the catalytic
core. The anaphase-promoting complex is
delineated by a lattice-like shell comprised
of a catalytic “platform” containing the subunits APC1, APC4, APC5, and APC15 and
an “arc lamp” scaffolding structure of the
TPR lobe containing the subunits APC3,
APC6, APC7, APC8, APC10, APC12,
APC13, and APC16. Together with Cdh1
or Cdc20, APC10 contributes to the substrate recognition module. This figure was adapted by permission from Macmillan Publishers
Ltd.: Nature (Chang et al. 2014) # 2014.
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inhibits the catalytic activity of the anaphase-promoting
complex. Components of the mitotic checkpoint (MCC),
including the proteins BubR1, Bub3, and Mad2, associate
with the anaphase-promoting complex and thereby inhibit
its activity (Hwang et al. 1998; Sudakin et al. 2001; Tang
et al. 2001). Single-particle EM analyses have revealed
that the MCC proteins interact with Cdc20–APC within
a region that overlaps with the Cdc20-binding site (Herzog
et al. 2009), thus inhibiting the binding of substrates of
Cdc20–APC. The MCC proteins also directly contact the
APC2–APC11 catalytic module (Herzog et al. 2009), suggesting that it may interfere with the catalytic core of
Cdc20–APC.
In addition to endogenous Cdh1–APC and Cdc20–APC
inhibitors, chemical inhibitors have been identified. The
small molecule tosyl-L-arginine methyl ester (TAME)
binds Cdh1–APC and Cdc20–APC and blocks ubiquitin ligase activation (Verma et al. 2004; Zeng et al. 2010; Zeng
and King 2012). Because TAME structurally resembles the
IR tail of Cdh1 and Cdc20, TAME binds the site of the IR
tail-binding region within the anaphase-promoting complex, thereby interfering with the interaction with
Cdc20 or Cdh1 (Zeng et al. 2010). Whereas TAME is a potent inhibitor of Cdh1–APC and Cdc20–APC in Xenopus
extracts in vitro, a cell-permeable variant, proTAME,
has been generated that is processed by intracellular esterases to yield the compound TAME (Zeng et al. 2010). Interestingly, proTAME may be activated selectively in a cell
type-specific manner (Zeng et al. 2010). The small molecule apcin also inhibits the anaphase-promoting complex
but shows more selective inhibition of Cdc20–APC (Sackton et al. 2014). Apcin occupies the D-box-binding pocket
in the WD40 domain of Cdc20, thereby competitively
blocking the binding of D-box-containing substrates
with Cdc20 (Sackton et al. 2014). Although proteins that
inhibit Cdh1–APC have been used in studies in the nervous system (Konishi et al. 2004; Huang et al. 2015), the potential utility of small molecule inhibitors of Cdh1–APC
and Cdc20–APC in neurobiology has remained largely
untapped.
The functions of the anaphase-promoting complex were
first characterized in proliferating cells. It promotes the
transition of cells from metaphase to anaphase during
cell division (Irniger et al. 1995; King et al. 1995), which
is mediated by the ordered degradation of cyclins, securin,
mitotic kinases, and microtubule motors and assembly
factors (Harper et al. 2002; Peters 2006; Sivakumar and
Gorbsky 2015). Cdc20–APC and Cdh1–APC control distinct temporal phases of the cell cycle. While Cdc20–
APC drives anaphase in early mitosis, Cdh1–APC plays
key roles in mitotic exit and G1 phase of the cell cycle (Peters 2006; Sivakumar and Gorbsky 2015). The activity of
Cdh1–APC and Cdc20–APC is tightly controlled by
post-translational modifications, including phosphorylation and ubiquitination as well as interactions with inhibitors in cycling cells (Reimann et al. 2001; Kraft et al.
2003; Peters 2006; Pesin and Orr-Weaver 2008). Cyclin-dependent kinases (CDKs) phosphorylate the anaphase-promoting complex, which promotes its association with
Cdc20 (Kotani et al. 1999; Kramer et al. 2000), whereas
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phosphorylation of Cdh1 triggers its dissociation from
the anaphase-promoting complex (Zachariae et al. 1998;
Kramer et al. 2000). Characterization of the functions
and regulation of Cdh1–APC and Cdc20–APC in dividing
cells has provided invaluable clues for our understanding
of the novel functions and mechanisms of the anaphasepromoting complex in the nervous system.
Identification of functions of the anaphase-promoting
complex in the nervous system
While studies of Cdc20–APC and Cdh1–APC have occupied the leading edge of cell cycle research since its identification in the mid 1990s, early clues suggested that the
anaphase-promoting complex might also have functions
in post-mitotic tissues beyond the control of the cell cycle. Components of Cdh1–APC were found ubiquitously
expressed in post-mitotic neurons, including in adult
mouse and human brains (Gieffers et al. 1999). However,
it was not until 2004 that the first neuronal function of
the anaphase-promoting complex was identified in the
mammalian brain (Konishi et al. 2004). Konishi et al.
(2004) discovered that Cdh1–APC plays a critical role in
the control of axon growth and patterning in the rodent
cerebellar cortex. Other studies identified functions for
Cdh1–APC in synapse development and function in flies
and nematodes (Juo and Kaplan 2004; Van Roessel et al.
2004). Since these early reports over a decade ago, a large
number of studies have uncovered additional functions
and mechanisms of the anaphase-promoting complex in
the nervous system (Fig. 2). The picture emerging from
these investigations is that Cdh1–APC and Cdc20–APC
play pleiotropic roles in distinct stages of nervous system
development and function.
Control of neurogenesis and gliogenesis by Cdh1–APC
The function of Cdh1–APC in neural precursors was first
characterized in Cdh1 heterozygous mutant mice. Although Cdh1+/– mice have little or no defects in the structure of the nervous system, a specific set of neural
progenitor cells in the subventricular zone show increased
proliferation in the mutant mice (Garcia-Higuera et al.
2008). The function of Cdh1–APC in neurogenesis in the
cerebral cortex was further characterized in conditional
Cdh1 knockout mice using the Nestin-Cre driver as well
as in embryo-restricted Cdh1 knockout mice using the
Sox2-Cre driver (Delgado-Esteban et al. 2013; Eguren
et al. 2013). Conditional knockout of Cdh1 in neural progenitor cells in both of these models impairs cortical neurogenesis due to delay of mitotic exit, accelerated entry
into the S phase, replicative stress, and p53-induced apoptotic cell death. Thus, conditional knockout of Cdh1 reduces the number of cortical neurons and hence cortical
size and thickness. Conditional knockout of Cdh1 induced by Nestin-Cre in neural progenitors leads to increased abundance of previously identified Cdh1–APC
substrates, including Aurora A, Aurora B, Tpx2, and Cyclin B1 (Fig. 3A; Eguren et al. 2013), which consequently
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Figure 2. Substrates of the anaphase-promoting complex in the nervous system. Substrates of Cdh1–APC and Cdc20–APC and their roles
in the nervous system are shown. SnoN, Id2, Smurf1, and p250GAP are substrates of Cdh1–APC in the regulation of axon growth in the
rodent cerebellum. Liprin-α is a substrate of Cdh1–APC in the regulation of synaptic size and transmission at the Drosophila neuromuscular junction (NMJ). Casein kinase 1δ (CK1δ) is a substrate of Cdh1–APC in the regulation of neurogenesis in the rodent cerebellum. Loco
is a substrate of Cdh1–APC in the regulation of gliogenesis in Drosophila. Skp2 is a substrate of Cdh1–APC in the regulation of cortical
neuronal differentiation. Cyclin B1 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (Pfkfb3) are substrates of Cdh1–APC in
the regulation of neuronal cell death. FMRP is a substrate of Cdh1–APC in the regulation of hippocampal mGluR-dependent long-term
depression (mGluR-LTD). GluR1 is a substrate of Cdh1–APC in the regulation of EphA4-dependent homeostatic plasticity in cortical neurons. Id1 and FEZ1 are substrates of Cdc20–APC in the regulation of dendrite growth in the cerebellum and hippocampus, respectfully.
NeuroD2 is a substrate of Cdc20–APC in the regulation of presynaptic differentiation in the cerebellum. Liprin-α is a substrate of
Cdc20–APC in the regulation of GABA release at the Caenorhabditis elegans NMJ.

results in shorter G1 and premature entry into the S phase
of the progenitors. Cdh1 depletion-induced replicative
stress and proliferative defects can be rescued by moderate
inhibition of Cdks in Cdh1 knockout neural progenitors,
suggesting that inappropriate activation of Cdks may account for the Cdh1 depletion-induced phenotypes in cortical progenitor cells (Eguren et al. 2013).
Cdh1–APC has also been reported to control neurogenesis in the cerebellum via degradation of the protein kinase casein kinase 1δ (CK1δ) (Fig. 3A; Penas et al. 2015).
Knockdown of CK1δ by siRNA or pharmacologically by
small molecule inhibitors leads to cell cycle arrest in granule neuron progenitors, suggesting that CK1δ promotes
the proliferation of granule neuron progenitors. Cdh1–
APC triggers the ubiquitination and consequent degrada-

tion of CK1δ in granule neuron progenitors (Penas et al.
2015), suggesting that Cdh1–APC might promote cell cycle exit and consequent granule neuron differentiation.
Surprisingly, however, conditional knockout of Cdh1 in
granule neuron progenitors fails to alter the development
of the mouse cerebellum even though this leads to increased levels of CK1δ in these cells (Penas et al. 2015).
Cdh1 is up-regulated in primary neural stem cells upon
neuronal differentiation in response to retinoic acid (Yao
et al. 2010), suggesting a potential role for Cdh1–APC in
neuronal differentiation. Consistent with these results,
ablation of Cdh1 in neural progenitors in conditional
Cdh1 knockout mice using the Sox2-Cre driver impairs
neuronal differentiation (Delgado-Esteban et al. 2013). Primary cortical neuron cultures prepared from Sox2-Cre-
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Figure 3. The anaphase-promoting complex regulates neurogenesis, gliogenesis, and glial migration.
(A) Cdh1–APC controls neurogenesis in the cerebral
cortex and cerebellum and gliogenesis in Drosophila.
Cdh1–APC promotes cortical neurogenesis via degradation of the cell cycle proteins Aurora A/B, Tpx2,
and Cyclin B1 in neural precursor cells. In the cerebellum, Cdh1–APC may control neurogenesis via degradation of the protein kinase CK1δ. In Drosophila,
Cdh1–APC limits gliogenesis via degradation of
Loco, a regulator of G-protein signaling protein. (B)
In Drosophila, Cdh1–APC controls peripheral glial
migration along motor neuron axons. Cdh1–APC
acts non-cell-autonomously in the establishment of
a gradient of the immunoglobulin superfamily cell adhesion molecule Fas2 in motor neuron axons, leading
to low levels of Fas2 proximally and high levels distally, facilitating glial migration along motor neuron
axons.

induced conditional Cdh1 knockout mice contain a higher proportion of precursor cells and a lower proportion of
post-mitotic neurons compared with control cultures.
Correspondingly, the ventricular and subventricular zones
in conditional Cdh1 knockout mice contain a higher proportion of precursor cells and fewer post-mitotic neurons
(Delgado-Esteban et al. 2013), suggesting that Cdh1 promotes neuronal differentiation in the cerebral cortex.
Cdh1–APC regulates neuronal differentiation through rapid degradation of the protein Skp2, leading to the stabilization of the Cdk inhibitor p27 (Carrano et al. 1999; Cuende
et al. 2008), which in turn is thought to promote neuronal
differentiation of cortical progenitor cells (Cuende et al.
2008; Harmey et al. 2009; Delgado-Esteban et al. 2013).
The phosphorylation status of Cdh1 is critical in regulating Cdh1–APC function in neuronal differentiation.
Cdh1–APC activity increases in primary cortical neurons during the first 2 d in culture, which is associated
with dephosphorylation of Cdh1 by the protein phosphatase 2A (PP2A) (Delgado-Esteban et al. 2013). Incubation of cortical neurons with the PP2A inhibitor okadaic
acid or transfecting neurons with a phosphomimetic
form of Cdh1 inhibits neurite extension (Delgado-Esteban et al. 2013), suggesting that dephosphorylation of
Cdh1 by PP2A promotes Cdh1–APC function in neuronal differentiation.
Whereas Cdh1–APC promotes neurogenesis in the rodent cortex (Delgado-Esteban et al. 2013; Eguren et al.
2013), it limits gliogenesis in flies (Fig. 3A; Kaplow et al.
2008). Drosophila Cdh1 mutants have a significantly
higher number of glial cells in the brain. Conversely,
Cdh1 overexpression in flies markedly reduces the number of glial cells. The protein Loco, a regulator of G-protein
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signaling, has been identified as a substrate of Cdh1–APC
in the regulation of gliogenesis (Kaplow et al. 2008). Cdh1
interacts with Loco in the Drosophila larva brain, leading
to its ubiquitination and consequent degradation. Loss-offunction Loco mutant flies harbor a reduced number of glial cells (Kaplow et al. 2008). Whether Cdh1–APC suppresses gliogenesis in the mammalian nervous system
remains to be determined. Together, studies of Cdh1–
APC in precursor cell differentiation suggest that Cdh1–
APC promotes neurogenesis and limits gliogenesis.
Whether Cdh1–APC plays an instructive cell-intrinsic role
in cell fate specification in the same population of neural
precursors is unknown.
The function of Cdh1–APC in glia extends beyond the
control of their differentiation to influencing their migration in Drosophila (Fig. 3B). In genetic screens using
ethyl methanesulfonate (EMS) mutagenesis, Cdh1 mutants show markedly reduced peripheral glial migration
along motor neuron axons, suggesting that Cdh1–APC
is required for glial migration (Silies and Klambt 2010).
Remarkably, Cdh1 acts non-cell autonomously in regulating glial cell migration. Cdh1 is required for the
establishment of a gradient of the immunoglobulin superfamily cell adhesion molecule Fasciclin 2 (Fas2) in motor
neuron axons, leading to low levels of Fas2 proximally
and high levels distally (Silies and Klambt 2010). Loss
of Fas2 graded distribution in motor neuron axons of
Cdh1 mutants causes impaired migration of peripheral
glia cells (Silies and Klambt 2010). However, whether
Cdh1–APC plays a direct role in ubiquitinating Fas2 remains to be determined, and a role for Cdh1–APC in
the regulation of glial migration in vertebrates still remains to be explored.
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Although Cdh1–APC functions have been characterized in neurogenesis and gliogenesis, the potential roles
of Cdc20–APC in the biology of neural precursors in the
developing nervous system have remained largely unexplored. Loss-of-function Cdc20 mutant mice have been
generated from a gene trap embryonic stem cell clone containing a splicing acceptor and β-geo sequence inserted
into intron 9 of the Cdc20 gene (Li et al. 2007). The predicted Cdc20 gene trap allele (Cdc20gt) encodes a fusion of 440
amino acids of the N-terminal portion of Cdc20 with
β-geo. The loss-of-function Cdc20 mutant in Cdc20gt/gt
mice triggers metaphase arrest at the two-cell embryonic
stage (Li et al. 2007). It is presumed that the essential
role of Cdc20–APC in cell proliferation extends to neural
precursor cells, although demonstration of this function
awaits generation of conditional Cdc20 knockout mice using precursor cell-specific drivers. In recent studies, a key
function for Cdc20–APC has been uncovered in the biology of human glioblastoma brain tumor stem cells (BTSCs)
(Mao et al. 2015). Using both knockdown and gain-of-function approaches, Mao et al. (2015) found that Cdc20–APC
promotes the self-renewal and invasiveness of patient-derived glioblastoma BTSCs. In a manner distinct from its
characteristic control of the cell cycle, Cdc20 interacts
with the transcription factor Sox2 in the nucleus through
the WD40 domain of Cdc20. Surprisingly, Cdc20–APC stabilizes Sox2 and hence enhances Sox2-dependent transcription in human BTSCs, leading to stem cell renewal
and invasiveness (Mao et al. 2015). The mechanism by
which Cdc20–APC promotes the accumulation of Sox2
in glioblastoma BTSCs and whether regulation of Sox2 extends to other stem cells during normal development remain important questions for future studies.

Role of the anaphase-promoting complex in neuronal
survival and metabolism
Studies of Cdh1–APC in rat cortical neurons have pointed
to a role for this major E3 ubiquitin ligase in the control of
cell survival and metabolism. Knockdown of Cdh1 in rat
cortical neurons by siRNAs leads to the accumulation of
Cyclin B1 and aberrant entry into S phase and apoptotic
cell death (Almeida et al. 2005). In subsequent studies,
Cdk5 phosphorylation of Cdh1 has been shown to inhibit
Cdh1–APC function in NMDA- or glutamate-induced
neural excitotoxicity in cortical neurons, leading to Cyclin B1 accumulation, p27 depletion, aberrant cell cycle
entry, and apoptotic neuronal cell death (Maestre et al.
2008; Veas-Perez de Tudela et al. 2015a,b). These studies
suggest that Cdh1–APC may promote the survival of cortical neurons.
Interestingly, Cdh1–APC may control neuronal survival via a second substrate that plays a key role in cell
metabolism (Herrero-Mendez et al. 2009; Rodriguez-Rodriguez et al. 2012). The glycolytic enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3(Pfkfb3)has
been identified as a substrate of Cdh1–APC in rat cortical neurons. Pfkfb3 generates fructose-2,6-bisphosphate,
which activates 6-phophofruto-1-kinase (Pfk1), the rate-

limiting enzyme in glycolysis (Rapoport et al. 1976; Hue
and Rider 1987). Under baseline conditions in primary cortical neurons, the levels of Pfkfb3 are low. However, upon
Cdh1 knockdown, Pfkfb3 protein accumulates in neurons
(Herrero-Mendez et al. 2009). Conversely, overexpression
of Cdh1 in astrocytes, which have high levels of Pfkfb3,
leads to down-regulation of Pfkfb3. Cdh1 interacts with
Pfkfb3 via a KEN box, and a Pfkfb3 mutant protein in
which the KEN box is mutated accumulates in neurons
(Herrero-Mendez et al. 2009). Notably, knockdown of
Cdh1 or up-regulation of Pfkfb3 activates glycolysis in
neurons. The up-regulation of Pfkfb3 also reduces the consumption of glucose via the pentose phosphate pathway,
leading to the accumulation of reactive oxygen species
and apoptotic cell death. Thus, Cdh1–APC-mediated degradation of Pfkfb3 in neurons may inhibit glycolysis and
maintain the antioxidant status of neurons (Herrero-Mendez et al. 2009). In subsequent studies, stimulation of the
glutamate receptor NMDAR has been reported to stabilize
Pfkfb3 secondary to Cdk5-mediated inhibition of Cdh1–
APC activity (Rodriguez-Rodriguez et al. 2012). It will be
important in future studies to determine the circumstances in which Cdh1–APC regulates neuronal survival via the
accumulation of Cyclin B or Pfkfb3 in the mammalian
brain in vivo.
The connection between neuronal survival and the
anaphase-promoting complex has also been demonstrated
in Drosophila larva brain neural stem cells in which
Cdc20–APC promotes proliferation and concomitantly
suppresses necrosis (Kuang et al. 2014). In a genetic
screen, loss-of-function mutations of fzy (Cdc20) trigger
premature brain neuroblast loss through necrosis, which
occurs independently of Cdc20’s function in cell proliferation. Cdc20–APC suppresses necrosis in larva brain neural stem cells by antagonizing the oxidoreductase Aif and
the stress-activated protein kinase JNK signaling. In addition, p53 appears to promote cell death in these cells via
inhibition of Cdc20–APC-dependent survival (Kuang
et al. 2014). The Cdc20–APC substrate that regulates necrosis remains to be identified, and whether Cdc20–APC
regulates necrosis in neural stem cells in the mammalian
brain is unknown.

Regulation of neuronal morphogenesis by Cdh1–APC and
Cdc20–APC
Although the biological roles of the anaphase-promoting
complex in neural precursor cells might reflect functions
and mechanisms of this complex in proliferating cells, the
greatest surprises have come from studies of this complex
in post-mitotic neurons (Juo and Kaplan 2004; Konishi
et al. 2004; Van Roessel et al. 2004). The first insights
into the role of the anaphase-promoting complex in the
nervous system came from studies of Cdh1–APC in neuronal morphogenesis (Fig. 4A; Konishi et al. 2004). Using
a knockdown approach in granule neurons of the rodent
cerebellar cortex, Konishi et al. (2004) discovered that
Cdh1–APC selectively limits the growth of axons but
not dendrites. Expression of the Cdh1–APC inhibitor
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Figure 4. The anaphase-promoting complex regulates neuronal morphogenesis. (A) Cdh1–APC regulates axon growth in the cerebellum
granule neurons. Cdh1–APC operates in the nucleus to limit axon growth by targeting the transcriptional regulators SnoN and Id2 and the
E3 ubiquitin ligase Smurf1 for degradation. Cdh1–APC also operates in the cytosol to limit axon growth by targeting Smurf1 and the RhoGAP p250GAP for degradation and disinhibiting the negative effect of the small GTPase RhoA on axon growth. (B) In granule neurons of
the cerebellum, Cdc20–APC operates at the centrosome to drive elaboration of dendrite arbors by targeting the helix–loop–helix (HLH)
protein Id1 for degradation. At the centrosome, histone deacetylase 6 (HDAC6) promotes the polyubiquitination of Cdc20, whereas
the deubiquitinase USP44 deubiquitinates Cdc20. Polyubiquitination of Cdc20 enhances Cdc20–APC activity, whereas the protein kinase CaMKIIβ inhibits centrosomal Cdc20–APC signaling, and the activity of CaMKIIβ is stimulated in turn by the calcium channel
TRPC5. In hippocampal dentate gyrus granule neurons, Cdc20–APC also operates at the centrosome to drive elaboration of dendrite arbors by targeting the schizophrenia-linked protein FEZ1 for degradation. At the centrosome in the hippocampal neurons, HDAC11 deacetylates and inhibits BubR1, and BubR1 suppresses Cdc20–APC activity for dendrite growth.

Emi1 or expression of a dominant interfering form of the
catalytic subunit APC11 in granule neurons phenocopied
the Cdh1 knockdown-induced increase in axon length in
granule neurons (Konishi et al. 2004). To characterize the
role of Cdh1–APC in the control of granule neuron axon
growth in the brain, Konishi et al. (2004) developed and
used an in vivo RNAi approach in postnatal rat pups. These
studies revealed that Cdh1–APC controls the growth and
patterning of granule neuron parallel fiber axons in the rodent cerebellum in vivo (Konishi et al. 2004).
To identify the mechanisms by which Cdh1–APC regulates axon growth in post-mitotic neurons, Stegmuller
et al. (2006) characterized the subcellular locale of Cdh1
function in granule neurons. In structure–function analyses of an RNAi-resistant form of Cdh1 in the background
of Cdh1 RNAi, Cdh1–APC operates in the nucleus rather
than the cytoplasm to control axon growth. The transcriptional regulator SnoN has been identified as a substrate of
neuronal Cdh1–APC in granule neurons (Fig. 4A). Cdh1–
APC interacts with SnoN and stimulates the ubiquitination and consequent degradation of SnoN in granule neurons. Consistent with a critical role for SnoN in axon
growth, knockdown of SnoN reduces axon length in granule neurons and triggers substantial loss of parallel fiber
axons in the rodent cerebellum in vivo (Stegmuller et al.
2006). SnoN knockdown suppresses the Cdh1 knockdown-induced axon phenotype in granule neurons, consistent with the conclusion that Cdh1–APC operates
upstream of SnoN in the regulation of axon growth in
the mammalian brain (Stegmuller et al. 2006).
How the Cdh1–APC substrate SnoN promotes axon
growth has also been characterized. Surprisingly, whereas
SnoN typically operates as a transcriptional corepressor
(Luo 2004; Pot and Bonni 2008), SnoN acts as a transcrip-
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tional activator in promoting axon growth (Ikeuchi et al.
2009). SnoN forms a complex with the transcriptional
coactivator p300 and stimulates expression of the signaling scaffold protein Ccd1 (Fig. 4A), which is enriched at
the axon terminal. Ccd1 activates the axon growth-promoting kinase JNK (Ikeuchi et al. 2009). Ccd1 knockdown
mimics the effects of SnoN knockdown, including reducing the formation of parallel fiber formation in vivo, and
suppresses SnoN-mediated axon growth (Ikeuchi et al.
2009). Beyond promoting the growth of axons in the developing cerebellum (Stegmuller et al. 2006), SnoN may also
promote the regeneration of axons following injury (Do
et al. 2013). Consistent with this result, inhibition of
Cdh1–APC overrides the axon inhibitory effect of myelin
(Konishi et al. 2004; Lasorella et al. 2006).
Cdh1–APC regulates axon growth via additional substrates besides SnoN (Lasorella et al. 2006). Immunoprecipitation followed by mass spectrometry analyses led to
the identification of the helix–loop–helix (HLH) protein
Id2 as an interactor of Cdh1–APC (Fig. 4A; Lasorella
et al. 2006). Like SnoN, Id2 contains the Cdh1 recognition
motif, the D box, and undergoes APC-induced ubiquitination and consequent proteasome-dependent degradation.
Expression of Id2 with a D-box mutation in granule neurons promotes the growth of axons (Lasorella et al. 2006).
As a negative regulator of basic HLH (bHLH)-dependent
transcription (Sun et al. 1991), Id2 inhibits the expression
of a number of genes encoding proteins with roles in
axon growth inhibition (Lasorella et al. 2006). These results suggest that Cdh1–APC-induced degradation of
Id2 induces the expression of a program of axon growth
inhibitory signals. Like SnoN, Id2 may also promote the regeneration of axons following injury (Yu et al. 2011). Expression of the D-box mutant Id2 using adenovirus-based
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gene delivery in DRG neurons stimulates axon growth in
the lesioned dorsal ascending axons following dorsal
spinal cord hemisection (Yu et al. 2011), suggesting that inhibiting Cdh1–APC-mediated degradation of Id2 facilitates axon regeneration after spinal cord injury. By
inducing the degradation of SnoN and Id2, Cdh1–APC
therefore acts as a pivotal cell-intrinsic regulator of axon
growth by controlling the responsiveness of axons to extrinsic cues and intracellular signaling proteins.
Cdh1–APC limits axon growth via the ubiquitination
and consequent degradation of a third substrate, the E3
ubiquitin ligase Smurf1 (Fig. 4A; Kannan et al. 2012b).
Cdh1 interacts with Smurf1 and targets it for ubiquitination and degradation in a D-box-dependent manner.
Smurf1 stimulates axon growth in granule neurons by promoting the turnover of the small GTPase RhoA (Wang
et al. 2003; Kannan et al. 2012b), which characteristically
inhibits axon growth (Fournier et al. 2003; Govek et al.
2005). These findings suggest that the Cdh1–APC/Smurf1
pathway limits axon growth via activation of RhoA signaling. The RhoGAP p250GAP represents another target of
Cdh1–APC that operates upstream of RhoA in the control
of axon growth (Fig. 4A; Kannan et al. 2012a). Accordingly, the two targets of Cdh1–APC, Smurf1 and p250GAP,
synergistically promote axon growth by disinhibiting
the effect of RhoA on axon growth (Kannan et al. 2012a).
Whereas Cdh1–APC targets Smurf1 for degradation,
Cdh1–APC induction of p250GAP ubiquitination does
not lead to its degradation (Kannan et al. 2012a).
How Cdh1–APC function is regulated in the control of
axon growth has also been the subject of scrutiny. Thus
far, these investigations have benefited from studies of
Cdh1–APC regulation in proliferating cells. The TGFβ–
Smad signaling pathway promotes the ability of Cdh1–
APC to promote the degradation of SnoN in the G1 phase
of the cell cycle in dividing cells (Bonni et al. 2001; Stroschein et al. 2001; Wan et al. 2001). Analogously, TGFβ–
Smad2 signaling operates upstream of the Cdh1–APC/
SnoN pathway in the control of axon growth in granule
neurons, where knockdown of Smad2 stimulates axon
growth (Stegmuller et al. 2008). In epistasis analyses,
Smad2 acts upstream of SnoN and Cdh1–APC in the regulation of axon growth. Phosphorylation of Cdh1 figures
prominently in the regulation of Cdh1–APC function of
the cell cycle, whereby phosphorylation of Cdh1 on Cdk
sites disrupts its interaction with the anaphase-promoting
complex and inhibits Cdh1–APC function during S phase
and early mitosis (Zachariae et al. 1998; Kramer et al.
2000; Peters 2006). In post-mitotic granule neurons of
the rodent cerebellum, phosphorylation of Cdh1 at Cdk
sites inhibits the ability of Cdh1–APC to limit axon
growth (Huynh et al. 2009). Interestingly, a dephosphorylated mimic of Cdh1 in which nine sites of Cdk-induced
phosphorylation are replaced with alanine (9A) is found
in the nucleus, whereas the phosphorylated mimic in
which the nine sites are replaced with aspartate (9D) accumulates in the cytoplasm. Moreover, the 9A mutant is
found in low amounts, whereas the 9D mutant is stabilized and found in higher amounts. In structure–function
analyses, the dephosphorylated Cdh1 mimic (9A), but not

the phosphorylated Cdh1 mimic (9D), limits the growth of
axons in granule neurons (Huynh et al. 2009). Collectively, these studies suggest that Cdh1–APC is subject to control by both extrinsic cues and intracellular signaling
events in the control of axon growth.
While studies of Cdh1–APC in the nervous system
began over a decade ago, studies of Cdc20–APC in the
nervous system lagged behind, perhaps owing to the observation that, although Cdh1 is highly expressed in
post-mitotic neurons in the adult brain, little or no
Cdc20 appears to be expressed in adult brain neurons
(Gieffers et al. 1999). However, the situation changed
when Kim et al. (2009) discovered that Cdc20 is expressed
in post-mitotic neurons during development. In contrast
to Cdh1–APC regulation of axon growth (Konishi et al.
2004), Cdc20–APC drives the elaboration of dendrite arbors in the rodent cerebellum in vivo (Fig. 4B; Kim et al.
2009). Remarkably, Cdc20 is enriched at the centrosome
in granule neurons, and centrosomal localization is critical for the ability of Cdc20–APC to promote dendrite arbor elaboration (Kim et al. 2009).
The HLH protein Id1 has been identified as a substrate
of Cdc20–APC in the control of dendrite growth in granule
neurons (Fig. 4B; Kim et al. 2009). A proportion of Id1 is
localized at the centrosome in neurons. Cdc20 interacts with Id1 via a D box within Id1. Knockdown of
Id1 in granule neurons promotes the growth of dendrites
and suppresses the Cdc20 knockdown-induced dendrite
phenotype, suggesting that Cdc20–APC operates upstream of Id1 in neurons. Notably, although Id1 is an inhibitor of bHLH-dependent transcription, Id1 operates at
the centrosome to control dendrite growth in granule
neurons (Kim et al. 2009). Remarkably, Id1 regulates dendrite growth by interacting with the proteasome lid protein S5a and thereby inhibiting proteasome function at
the centrosome in granule neuron (Puram et al. 2013).
Together, these studies suggest an intriguing interplay
between the function of the E3 ubiquitin ligase Cdc20–
APC and neuronal proteasomes at the centrosome in
the nervous system.
Cdc20–APC function in dendrite elaboration is regulated by activating and inhibitory signaling mechanisms
(Fig. 4B). Using a rational approach, Kim et al. (2009) found
that the centrosomally localized protein histone deacetylase 6 (HDAC6) interacts with and stimulates the activity of Cdc20–APC in neurons. Surprisingly, rather than
regulating Cdc20–APC through deacetylation of Cdc20,
HDAC6 promotes via its C-terminal ZnF-UBP domain
the polyubiquitinated state of Cdc20 and hence activates
Cdc20–APC function in dendrite arbor morphogenesis in
granule neurons. Consistent with the conclusion that the
polyubiquitination of Cdc20 per se stimulates the activity
of Cdc20–APC in dendrite growth, knockdown of the
Cdc20-specific deubiquitinase USP44 (Stegmeier et al.
2007) increases the polyubiquitinated state of Cdc20 in
granule neurons and stimulates dendrite growth in
a Cdc20-dependent manner. These results suggest that
the polyubiquitination of Cdc20 stimulates centrosomal Cdc20–APC signaling and consequent dendrite
elaboration.
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In contrast to HDAC6 activation of centrosomal
Cdc20–APC signaling, the protein kinase CaMKIIβ inhibits centrosomal Cdc20–APC signaling in granule neurons
(Fig. 4B; Puram et al. 2011a). Remarkably, CaMKIIβ localizes to the centrosome via a centrosomal targeting sequence (CTS) and operates independently of CaMKIIα,
the other major brain CaMKII isoform (Hudmon and
Schulman 2002), to promote granule neuron dendrite retraction and pruning (Puram et al. 2011a). CaMKIIβ catalyzes the phosphorylation of Cdc20 at a distinct site,
Ser51, and thereby promotes the dispersion of Cdc20
away from the centrosome, leading to the inhibition of
centrosomal Cdc20–APC activity in granule neurons.
Consequently, CaMKIIβ induces the transition from granule neuron dendrite elaboration to dendrite pruning in the
rodent brain (Puram et al. 2011a). The activity of CaMKIIβ
is stimulated in turn in granule neurons of the cerebellum
by the calcium channel TRPC5 (Puram et al. 2011b). Collectively, these studies suggest that a TRPC5/CaMKIIβ
pathway triggers the phosphorylation of Cdc20 and consequently suppresses centrosomal Cdc20–APC signaling in
neurons.
Cdc20–APC has also been implicated in promoting dendrite growth in the postnatal mouse hippocampus (Fig. 4B;
Watanabe et al. 2014). Expression of Cdc20 stimulates,
whereas knockdown of Cdc20 impairs, dendrite growth
in dentate gyrus granule neurons. In these studies, the
schizophrenia-linked protein FEZ1 has been identified as
a substrate of Cdc20–APC. Upstream, the protein kinase
BubR1 inhibits the function of Cdc20–APC in dendrite
growth. Further upstream, the centrosomally localized
HDAC11 triggers the deacetylation of BubR1 and thereby
stimulates the activity of Cdc20–APC in dendrite growth.
Interestingly, HDAC11 forms a complex with HDAC6,
and these centrosomally localized proteins synergistically
promote dendrite growth (Watanabe et al. 2014). These results suggest that centrosomal Cdc20–APC signaling is a
key pathway in the regulation of dendrite morphogenesis
in the mammalian brain.

The anaphase-promoting complex regulates synapse
formation and function
Beyond the regulation of axon and dendrite morphogenesis, the anaphase-promoting complex has been implicated
directly in neuronal connectivity by controlling synapse
formation (Fig. 5). Early clues to the role of the anaphase-promoting complex in synapse development came
from investigations in flies and nematodes (Juo and
Kaplan 2004; Van Roessel et al. 2004). Flies with loss-offunction mutations of APC2 in which the entire cullin
domain of APC2 is removed display expanded neuromuscular junction (NMJ) with an increase in the number of
presynaptic boutons (Van Roessel et al. 2004). Expression
of APC2 in motor neurons but not muscle reverses the
NMJ overgrowth phenotype. The protein Liprin-α represents a downstream target of Cdh1–APC in the regulation
of synaptic size in the presynaptic site (Fig. 5). Independently of its effects on the presynaptic side, Cdh1–APC
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Figure 5. The anaphase-promoting complex regulates synapse
development and function. At presynaptic sites, Cdh1–APC regulates synapse size at Drosophila NMJ via degradation of the protein Liprin-α. Cdc20–APC regulates GABA release and inhibitory
synaptic transmission at C. elegans NMJ also by targeting Liprinα for degradation. Cdc20–APC promotes presynaptic differentiation in granule neurons of the cerebellum via degradation of the
transcription factor NeuroD2. At postsynaptic sites, Cdh1–APC
limits expression of glutamate receptors GluRIIa at Drosophila
NMJ and controls the endocytosis or recycling of GLR-1 in C. elegans ventral cord interneurons, thus regulating excitatory synaptic strength in flies and nematodes. In the regulation of synaptic
plasticity, Cdh1–APC facilitates EphA4-dependent homeostatic
plasticity by targeting the glutamate receptor GluR1 for degradation in cortical neurons. Cdh1–APC drives mGluR-LTD by targeting the fragile X mental retardation protein FMRP for
degradation in the hippocampus.

also controls synaptic function on the postsynaptic side
of the NMJ in Drosophila (Van Roessel et al. 2004). The
APC2 mutation-induced postsynaptic phenotype is rescued by expression of APC2 in muscle cells but not motor
neurons. Associated with this phenotype, APC2 mutant
flies have higher levels of the glutamate receptor GluRIIa
at the NMJ (Fig. 5; Van Roessel et al. 2004). In immunofluorescence analyses, APC2, Cdc27, and Cdh1, but not
Cdc20, immunoreactivity is present at the NMJ synapse
(Van Roessel et al. 2004), suggesting that Cdh1–APC regulates the size of Drosophila NMJ synapses. Collectively,
these results suggest that Cdh1–APC regulates presynaptic
size and postsynaptic function at the NMJ in Drosophila.
In nematodes, synapses in ventral cord interneurons
have been analyzed using a fusion of the glutamate receptor GLR-1 and GFP (GLR-1::GFP) (Rongo et al. 1998). Temperature-sensitive mutations of several core components
of the anaphase-promoting complex lead to increased
width, but not density or amplitude, of GLR-1::GFP
puncta in these interneurons (Juo and Kaplan 2004). This
phenotype is mimicked in transgenic nematodes expressing dominant-negative Cdh1 but not dominant-negative
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Cdc20 (Juo and Kaplan 2004). These results suggest that
Cdh1–APC regulates the abundance of GLR-1 receptors
in ventral cord interneurons in nematodes (Fig. 5). GLR-1
is unlikely to be the direct target of Cdh1–APC; rather,
Cdh1–APC appears to regulate endocytosis or recycling
of GLR-1, although the direct substrate in this process remains to be identified. Notably, in primary cortical neurons in vertebrates, Cdh1–APC has been suggested to
directly induce the ubiquitination and consequent degradation of the glutamate receptor GluR1 during EphA4-dependent homeostatic plasticity (Fu et al. 2011).
Although most studies of the anaphase-promoting complex in synapse biology have focused on the role of Cdh1–
APC, Yang et al. (2009) uncovered a critical role for
Cdc20–APC in presynaptic differentiation in the mammalian brain. Knockdown of Cdc20 dramatically reduces
the number of granule neuron parallel fiber active zone
protein-containing boutons that are contiguous with
PSD95-positive postsynaptic densities in the rodent cerebellum. This effect is not mimicked by knockdown of
Cdh1, suggesting a selective role for Cdc20–APC in promoting the number of presynaptic sites in the cerebellar
cortex. In primary granule neurons, Cdc20–APC promotes
the formation of functional presynaptic sites. Cdc20–APC
represents the first identified E3 ubiquitin ligase that
drives presynaptic development in the mammalian brain.
How does Cdc20–APC regulate presynaptic differentiation? The transcription factor NeuroD2 has been identified as a substrate of neuronal Cdc20–APC (Fig. 5; Yang
et al. 2009). Cdc20 interacts with NeuroD2 via a conserved D box. NeuroD2 is ubiquitinated in granule neurons, and knockdown of Cdc20 increases the levels of
endogenous NeuroD2 in granule neurons. Importantly,
knockdown of NeuroD2 leads to an increase in the number of presynaptic boutons in granule neurons and suppresses the Cdc20 knockdown-induced impairment of
presynaptic differentiation. NeuroD2 suppresses the formation of presynaptic boutons in granule neurons via
the synaptic regulator Complexin 2 (Yang et al. 2009).
Collectively, these results suggest that Cdc20–APC and
NeuroD2 form components of a ubiquitin signaling pathway that regulates presynaptic development. Several
questions remain to be addressed in studies of Cdc20–
APC regulation of presynaptic differentiation. Among
these questions, one of the most interesting is the subcellular locale of Cdc20–APC action in presynaptic differentiation. In the regulation of neuronal morphogenesis,
Cdh1–APC acts in the nucleus to control axon growth,
whereas Cdc20–APC operates at the centrosome to drive
dendrite arbor elaboration. Whether Cdc20–APC acts in
the nucleus, centrosome, or elsewhere within the cell to
promote the ubiquitination of the transcription factor
NeuroD2 remains an open question.
Whereas much of the focus on synaptic roles of the anaphase-promoting complex has been on excitatory synapses, intriguing findings by Kowalski et al. (2014) suggest
that Cdc20–APC may also play a crucial role in the regulation of inhibitory synapses by GABAergic motor neurons
in C. elegans (Fig. 5). In nematodes, body wall muscles receive excitatory synaptic inputs by cholinergic motor neu-

rons as well as inhibitory synaptic inputs by GABAergic
motor neurons (Richmond and Jorgensen 1999; Gao and
Zhen 2011). Temperature-sensitive mutations of APC4,
Cdc16 (APC6), APC1, and Cdc23 (APC8) as well as knockdown of Cdc20, but not a Cdh1 mutant, impair GABA
release at GABAergic motor neurons in C. elegans, as measured by inhibitory postsynaptic currents (IPSCs) at the
NMJ and behavioral sensitivity to a cholinesterase inhibitor (Kowalski et al. 2014). Cdc20–APC mutants lead to increased levels of the protein Liprin-α presynaptically in
GABAergic neurons (Kowalski et al. 2014), but how
Cdc20–APC regulates presynaptic release of GABA remains to be fully elucidated.

Cdh1–APC promotes synaptic plasticity and learning
and memory
In view of functions of the anaphase-promoting complex
in synapse formation, the high level of expression of
Cdh1–APC in the brain into adulthood suggests that
this major E3 ubiquitin ligase may have roles in adaptive
responses of the nervous system to experience. Consistent
with this prediction, Cdh1–APC has been implicated in
several forms of synaptic plasticity, including long-term
potentiation (LTP), mGluR-dependent long-term depression (mGluR-LTD), and homeostatic synaptic plasticity
(Fig. 5; Li et al. 2008; Fu et al. 2011; Pick et al. 2013a,b;
Huang et al. 2015). Cdh1–APC regulates synaptic plasticity in several areas of the brain, including the hippocampus, amygdala, and cortex (Li et al. 2008; Fu et al. 2011;
Pick et al. 2013a; Huang et al. 2015). Consistent with
these results, conditional knockout of Cdh1 or APC2
leads to cognitive impairments in spatial learning and
fear memory (Kuczera et al. 2011; Pick et al. 2013a,b).
The first description of Cdh1–APC’s function in synaptic plasticity came from studies of mice generated from a
gene trap embryonic stem cell clone containing a splicing
acceptor and β-geo sequence inserted into intron 5 of the
Cdh1 gene (Li et al. 2008). The predicted Cdh1 gene trap
allele (Cdh1gt) encodes a fusion of 125 amino acids of
the N-terminal portion of Cdh1 with β-geo. Although constitutive Cdh1gt/gt mice die in early development, mice
heterozygous for the Cdh1gt allele have little or no gross
brain morphological abnormalities despite reduction of
Cdh1 protein levels by ∼50% in the brain. Synapses in
the heterozygous mice show no abnormalities in basal
transmission or presynaptic short-term plasticity. However, late-phase LTP (L-LTP) evoked by multiple trains of
high-frequency stimulation (HFS) at 100 Hz, but not early-phase LTP (E-LTP) evoked by a single train of HFS, is
impaired in acute hippocampal slices from Cdh1 heterozygous mice. L-LTP in slices from Cdh1 heterozygous
mice decays to baseline levels with more rapid kinetics
when compared with slices from control littermates
(Li et al. 2008). To date, substrates of Cdh1–APC that mediate regulation of L-LTP remain unknown.
In contrast to heterozygous Cdh1+/gt mice (Li et al.
2008), conditional Cdh1 knockout mice generated using
a CaMKII-Cre driver have no abnormalities of LTP in

GENES & DEVELOPMENT

631

Downloaded from genesdev.cshlp.org on April 5, 2016 - Published by Cold Spring Harbor Laboratory Press

Huang and Bonni

the hippocampus (Pick et al. 2013a), suggesting that impairment of L-LTP in the Cdh1 heterozygous mice may reflect a requirement for Cdh1 in the development of the
hippocampus. On the other hand, the CaMKII-Cre-induced conditional Cdh1 knockout mice display modest
impairment of L-LTP in the amygdala (Pick et al. 2013a).
This phenotype is associated with increased abundance
of the postsynaptic density protein Shank1 and glutamate
receptor NR2A in the amygdala of conditional Cdh1
knockout mice. However, whether ubiquitination and
degradation of these proteins mediate the effect of Cdh1–
APC on L-LTP in the amygdala remains unknown. Notably, Shank1 contains a D box, and its levels are also
increased in APC2-deficient primary hippocampal neurons (Hung et al. 2010), suggesting that Shank1 may represent a Cdh1–APC substrate.
Recent studies have uncovered a novel role for Cdh1–
APC in driving mGluR-LTD (Fig. 5; Huang et al. 2015).
Huang et al. (2015) found that conditional knockout of
Cdh1 in forebrain-specific knockout mice using the
Emx-Cre driver specifically impairs mGluR-LTD induced
in the hippocampus by the group 1 mGluR agonist DHPG
or a paired-pulse low-frequency stimulation paradigm. Expression of the Cdh1–APC inhibitor Emi1 in mice by in
utero electroporation phenocopies the conditional Cdh1
knockout-induced impairment in mGluR-LTD in the hippocampus, suggesting that Cdh1 acts in concert with the
anaphase-promoting complex to promote mGluR-LTD.
Structure–function analyses of Cdh1 expressed in the hippocampus in vivo by in utero electroporation in the background of conditional Cdh1 knockout mice reveal that
Cdh1 operates in the cytoplasm rather than the nucleus
to drive mGluR-LTD (Huang et al. 2015).
The fragile X syndrome protein FMRP has been identified as a novel substrate of Cdh1–APC in the control of
mGluR-LTD (Huang et al. 2015). The mGluR activator
DHPG stimulates the ubiquitination and consequent degradation of FMRP in the hippocampus (Hou et al. 2006;
Nalavadi et al. 2012). FMRP contains a conserved D
box, and Cdh1 interacts with FMRP via the D box.
DHPG-induced ubiquitination and degradation of FMRP
is blocked in the hippocampus of conditional Cdh1
knockout mice (Huang et al. 2015). Accordingly, the levels of FMRP increase in the hippocampus in conditional
Cdh1 knockout mice. Importantly, FMRP knockout,
which enhances mGluR-LTD (Huber et al. 2002), suppresses the conditional Cdh1 knockout-induced mGluRLTD phenotype (Huang et al. 2015). Collectively, these
findings define a Cdh1–APC/FMRP ubiquitin signaling
pathway that drives mGluR-dependent synaptic plasticity in the mammalian brain.
Cdh1–APC has also been implicated in homeostatic
synaptic plasticity (Fig. 5; Fu et al. 2011), which refers to
the capacity of neurons to regulate their own excitability
relative to network activity (Turrigiano 2008; Pozo and
Goda 2010). In Ephrin-A1/EphA4-mediated homeostatic
plasticity at excitatory synapses, activation of the receptor
EphA4 in primary cortical neurons in response to the ligand Ephrin-A1 induces chronic elevation of neural activity and results in down-regulation of excitatory synaptic
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transmission with decreased synaptic and surface GluR1
expression and reduced mEPSC frequency (Fu et al. 2007,
2011). Beginning with an interaction of EphA4 with a truncated fragment of APC2 in a yeast-two hybrid assay,
Fu et al. (2007, 2011) found that Cdh1–APC mediates
EphA4-dependent down-regulation of AMPA receptors
in cortical neurons in response to chronic elevation of synaptic activity. EphA4 interacts with APC2 in 293T cells
and cortical neurons, an interaction that is enhanced upon
exposure to Ephrin-A1. The glutamate receptor GluR1 appears to operate as a substrate of Cdh1–APC in the regulation of homeostatic plasticity. The ubiquitination and
degradation of GluR1 is dependent on Cdh1–APC in
293T cells. Knockdown of Cdh1 suppresses Ephrin-A1-induced down-regulation of GluR1 in cortical neurons.
These findings suggest a role for Cdh1–APC in the turnover of postsynaptic AMPAR during EphA4-dependent homeostatic synaptic plasticity in cortical neurons.
Because memory traces are thought to be encoded by alterations of synaptic connectivity among neurons (Martin
et al. 2000; Neves et al. 2008), the role of the anaphase-promoting complex in the regulation of neuronal connectivity and synaptic plasticity would be expected to impact the
cognitive behavior of animals and, in particular, learning
and memory. Several studies have probed the function of
Cdh1–APC in spatial learning and fear memory (Li et al.
2008; Kuczera et al. 2011; Pick et al. 2013a,b). In APC2 conditional knockout mice generated using the CaMKIIα-Cre
driver in which APC2 is depleted in adult forebrain excitatory neurons, Kuczera et al. (2011) characterized the
role of the anaphase-promoting complex in learning and
memory. Conditional APC2 knockout mice show normal
brain morphology, home cage behavior, motor coordination, basal anxiety, and depressive-like behavior, making
them suitable for studies of the anaphase-promoting complex in learning and memory. In a Pavlovian fear conditioning paradigm of associative fear memory in rodents
(Anagnostaras et al. 2000), animals are placed in a fear conditioning apparatus, and an aversive stimulus (a foot
shock) is paired with an auditory conditioned stimulus
within the novel environment. After training, freezing
behavior of the animals is measured in response to presentation of either the context (contextual fear conditioning)
or auditory stimulus in a different context (cued fear conditioning). Female mice with conditional knockout of
APC2 display increased freezing behavior during contextual memory assays performed 1 d after the electric shock.
Interestingly, when animals are subjected to a fear extinction paradigm in which animals are subjected to repetitive
presentation of the conditioned stimulus in the absence of
the unconditioned stimulus after they have already been
conditioned to associate the two stimuli, both male and female conditional APC2 knockout mice show higher freezing on all extinction trials (Kuczera et al. 2011). In addition
to impaired fear extinction, conditional knockout of APC2
also display impaired hippocampal-dependent spatial
memory using the Morris water maze (MWM) test of spatial learning and memory behavior in rodents, in which animals are placed in a large circular pool and trained to find
an invisible platform that allows them to escape the water
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by using various spatial cues (Kuczera et al. 2011). Because
APC2 is depleted in mature excitatory neurons rather than
during development in these mice, the function of the anaphase-promoting complex in fear extinction and spatial
memory may reflect its role in the regulation of synaptic
strength in the hippocampus or amygdala in the adult
brain.
In view of the high expression of Cdh1 in the adult
brain, the role of the anaphase-promoting complex in
learning and memory has been investigated on the basis
of Cdh1–APC activity. Constitutive heterozygous Cdh1
knockout mice (Cdh1+/gt) generated by Li et al. (2008)
have been subjected to learning and memory tests in contextual and cued fear conditioning. Whereas no difference
in cued fear conditioning have been observed, heterozygous Cdh1 knockout mice display impaired contextual
fear conditioning. These results suggest that Cdh1–APC
specifically regulates hippocampus-dependent memory.
To better elucidate the function of Cdh1–APC in learning and memory, Pick et al. (2013a) generated conditional
Cdh1 knockout mice using the CaMKIIα-Cre driver
in which Cdh1 is depleted in adult forebrain excitatory
neurons. Interestingly, phenotypes in conditional Cdh1
knockout and conditional APC2 knockout mice differ
even though similar CaMKIIα-Cre drivers have been
used in both studies (Kuczera et al. 2011; Pick et al.
2013a). Whereas conditional APC2 knockout mice do
not show abnormalities in explorative and locomotor
behavior in an open field paradigm (Kuczera et al. 2011),
conditional Cdh1 knockout mice spend less time in the
center and more time in the periphery of the open field
arena (Pick et al. 2013a), suggesting that knockout of
Cdh1, but not APC2, impairs exploration in a novel context. Likewise, whereas conditional APC2 knockout
mice display impaired spatial learning in the MWM paradigm (Kuczera et al. 2011), conditional knockout of Cdh1
does not show such impairment (Pick et al. 2013a). However, in a reversal learning paradigm of the MWM, in
which the hidden platform is moved to a different quadrant, conditional Cdh1 knockout mice show enhanced
ability to reverse the previously consolidated spatial
memory and establish new memory faster than control
animals (Pick et al. 2013a). These conditional Cdh1
knockout mice also show enhanced reversal learning in
a water-based Y maze (Pick et al. 2013a), another spatial
learning paradigm. Consistent with the constitutive heterozygous Cdh1 knockout mice but inconsistent with
the conditional APC2 knockout mice (Li et al. 2008; Kuczera et al. 2011), conditional Cdh1 knockout mice show
reduction in their freezing behavior in a contextual fear
conditioning paradigm 24 h after training (Pick et al.
2013a), suggesting that knockout of Cdh1 impairs contextual fear memory.
Another line of conditional Cdh1 knockout mice has
been generated using a neuron-specific enolase (Nse)-Cre
driver to delete Cdh1 in all neurons from the onset of differentiation (Pick et al. 2013b). These conditional Cdh1
knockout mice display normal spatial memory in both
the MWM and water-based Y maze as well as normal contextual fear memory. However, these mice show deficits

in learning flexibility. Although conditional Cdh1 knockout mice under CaMKIIα-Cre in another study show enhanced reversal learning in a water-based Y maze (Pick
et al. 2013a), conditional Cdh1 knockout mice under the
Nse-Cre driver display reduced reversal learning in the
same learning paradigm (Pick et al. 2013b). These mice
also have a diminished ability to extinguish previously
consolidated fear memory in the associative auditory
fear memory paradigm. Thus, the picture that emerges
is that Cdh1–APC may have a specific role in memory
flexibility.

Perspectives
More than a decade after the first description of a function
for the anaphase-promoting complex in the nervous system (Konishi et al. 2004), Cdh1–APC and Cdc20–APC
have emerged as major E3 ubiquitin ligases with pleiotropic roles in neurobiology. Several key themes and principles have emerged from studies of Cdh1–APC and
Cdc20–APC in the nervous system, which should guide
future investigations in this field.
The anaphase-promoting complex contributes to the
regulation of diverse aspects of neuronal development
and plasticity, from the control of neurogenesis and gliogenesis to neuronal survival and metabolism to axon
and dendrite morphogenesis to synaptic connectivity and
plasticity to the control of learning and memory. How
does the specificity of the anaphase-promoting complex
function arise? At least part of the answer may lie in the
principle that spatial localization of Cdh1–APC and
Cdc20–APC dictates its function (Yamada et al. 2013).
For example, nuclear localization of Cdh1–APC in granule
neurons of the developing cerebellum plays a critical role
in the ability of Cdh1–APC to regulate axon growth owing
to targeting transcriptional regulators in the nucleus
for ubiquitination and consequent degradation (Konishi
et al. 2004; Lasorella et al. 2006; Stegmuller et al. 2006).
On the other hand, Cdc20–APC operates at the centrosome to drive granule neuron dendrite arbor elaboration
by triggering the ubiquitination and degradation of a centrosomally localized substrate (Kim et al. 2009; Puram
et al. 2011a,b; Watanabe et al. 2014). Cdc20–APC function
in dendrite elaboration is also regulated by centrosomally
localized signals in granule neurons. Thus, the centrosome provides a hub for Cdc20–APC ubiquitin signaling
and hence specificity for its function in the control of dendrite morphogenesis. In hippocampal neurons, Cdh1–
APC acts outside the nucleus, in the cytoplasm, to drive
mGluR-LTD (Huang et al. 2015). Whether Cdh1–APC
and Cdc20–APC operate at additional subcellular locales
to specify other functions in the nervous system remains
to be determined.
Whereas both Cdh1–APC and Cdc20–APC have been
demonstrated to control neuronal morphogenesis and
synaptic connectivity during development, only Cdh1–
APC has been implicated in the control of synaptic plasticity and learning and memory in the adult brain
(Almeida et al. 2005; Li et al. 2008; Fu et al. 2011; Kuczera
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et al. 2011; Pick et al. 2013a,b; Huang et al. 2015). This is
perhaps not surprising in view of the high level of expression of Cdh1 in the adult brain (Gieffers et al. 1999). However, it will be interesting to determine whether Cdc20–
APC is expressed or activated in specific cell types or under specific circumstances in the adult brain. In addition
to identifying novel roles for Cdc20–APC in the adult
brain, it will be also interesting to probe the functions of
the anaphase-promoting complex regulated by Cdh1 or
Cdc20 in other cognitive functions and behaviors beyond
the control of learning and memory in the hippocampus
and amygdala.
The identification of Cdh1–APC and Cdc20–APC functions in the nervous system has expanded the list of substrates that are ubiquitinated by the anaphase-promoting
complex in cells. This trend is likely to continue in the
years ahead as additional roles for Cdh1–APC and
Cdc20–APC are uncovered in neurobiology. The use of
conditional knockout strategies for Cdh1 and Cdc20 will
be especially useful in this regard, as these regulators are
knocked out in distinct populations of neurons, and glial
cells in the nervous system should provide novel insights
into the functions and mechanisms of Cdh1–APC and
Cdc20–APC in the brain. For instance, while much of
the work on the anaphase-promoting complex in neurons
has focused on excitatory neurons and the control of excitatory synapses (Konishi et al. 2004; Kim et al. 2009; Yang
et al. 2009; da Fonseca et al. 2011; Fu et al. 2011; Huang
et al. 2015), studies in C. elegans suggest that Cdc20–
APC may also play important roles in GABAergic motor
neurons and the regulation of inhibitory synapses at the
NMJ (Kowalski et al. 2014). Thus, it will be interesting to
probe the role of Cdc20–APC in GABAergic interneurons
and in the control of inhibitory synapse formation and
function in the mammalian brain. Additional substrates
of Cdh1–APC and Cdc20–APC will be identified, starting
with new biological roles for the anaphase-promoting
complex. Alternatively, advanced proteomics approaches
also may be used to identify new substrates of Cdh1–
APC and Cdc20–APC as a starting point in these studies.
Characterization of novel functions of the anaphasepromoting complex in neuronal connectivity and plasticity has raised prospects that deregulation of Cdh1–APC
and Cdc20–APC ubiquitin signaling may also contribute
to neurological diseases. The recent identification of the
Cdh1–APC/FMRP ubiquitin signaling pathway in the
control of mGluR-LTD provides an example of how a novel link between Cdh1–APC and a protein whose mutations cause fragile X syndrome might lead to new
insights into intellectual disability and autism (Huang
et al. 2015). Fragile X syndrome patients harbor a large expansion (>200) of the CGG trinucleotide repeat within the
5′ untranslated region of the FMR1 gene, which leads to
the hypermethylation and consequent silencing of the
FMR1 gene (Bhakar et al. 2012; Santoro et al. 2012). Importantly, in a substantial proportion of fragile X syndrome patients as well as carriers of the FMR1 gene in
whom the CGG repeats expand to an intermediate level
(55–200), the FMR1 gene is not silenced but is reduced
in expression. Such fragile X syndrome patients and a sub-
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stantial proportion of the fragile X syndrome carriers with
the premutation have neuropsychological symptoms, including manifestation of autism spectrum disorder (Tassone et al. 2000; Farzin et al. 2006). If levels of FMRP
can be increased in these patients upon inhibition of
Cdh1–APC, such measures might be anticipated to reduce
cognitive impairments in these patients. It will be important to test this hypothesis by inhibiting Cdh1–APC in
mouse models that express premutation of the FMR1
gene (Entezam et al. 2007; Qin et al. 2011). Beyond the implications of Cdh1–APC/FMRP ubiquitin signaling in
neurological disease, characterization of functions of the
anaphase-promoting complex may provide clues for additional roles in disease. For instance, the ability of Cdh1–
APC to inhibit axon growth may be harnessed to generate
means of promoting axon growth upon inhibition of
Cdh1–APC. In addition, the role of Cdh1–APC in synaptic
plasticity and learning and memory raises the possibility
that deregulation of Cdh1–APC signaling may contribute
to disorders of memory. In future studies, it will be exciting to define the extent of anaphase-promoting complex
ubiquitin signaling in brain disorders and explore the potential for small molecule inhibitors of the anaphase-promoting complex in the treatment of these disorders.
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